Cancer chemopreventive activity of xanthohumol, a natural product derived from hop

Molecular Cancer Therapeutics

Volumn 1, Issue 11, 2002, Pages 959-969

  Gerhauser, Clarissa ^a   Alt, Axel ^b   Heiss, Elke ^a   Gamal Eldeen, Amira ^a   Klimo, Karin ^a   Knauft, Jutta ^a   Neumann, Isabell ^a   Scherf, Hans Rudolf ^a   Frank, Norbert ^a   Bartsch, Helmut ^a   Becker, Hans ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIOXIDANT; CARCINOGEN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ISOENZYME; MEMBRANE PROTEIN; PLANT EXTRACT; PROPIOPHENONE DERIVATIVE; PROSTAGLANDIN SYNTHASE; PTGS1 PROTEIN, MOUSE; XANTHOHUMOL;

ANIMAL; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL DIVISION; CHEMICAL MODEL; DOSE RESPONSE; DRUG ANTAGONISM; FLOW CYTOMETRY; HUMULUS; IC 50; KINETICS; METABOLISM; MOUSE; NEOPLASM; PRECANCER;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; APOPTOSIS; CARCINOGENS; CELL DIFFERENTIATION; CELL DIVISION; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; HUMULUS; INHIBITORY CONCENTRATION 50; ISOENZYMES; KINETICS; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MODELS, CHEMICAL; NEOPLASMS; PLANT EXTRACTS; PRECANCEROUS CONDITIONS; PROPIOPHENONES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; S PHASE;

EID: 0036728052     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Young, R. C. The sounds of silence. Nature (Lond.), 408: 141, 2000.
2. Sporn, M. B., Dunlop, N. M., Newton, D. L., and Smith, J. M. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs. Fed. Proc., 35: 1332-1338, 1976.
3. Theisen, C. Chemoprevention: what's in a name? J. Natl. Cancer Inst. (Bethesda), 93: 743, 2001. (Pubitemid 32514796)
4. Steele, V. E., Boone, C. W., Lubet, R. A., Crowell, J. A., Holmes, C. A., Sigman, C. C., and Kelloff, G. J. Preclinical drug development paradigms for chemopreventives. Hematol. Oncol. Clin. N. Am., 12: 943-961, 1998. (Pubitemid 28476034)
5. Alberts, D. S., and Garcia, D. J. An overview of clinical cancer chemoprevention studies with emphasis on positive Phase III studies. J. Nutr., 125 (Suppl): 692S-697S, 1995.
6. Kelloff, G. J., Crowell, J. A., Steele, V. E., Lubet, R. A., Boone, C. W., Malone, W. A., Hawk, E. T., Lieberman, R., Lawrence, J. A., Kopelovich, L., Ali, I., Viner, J. L., and Sigman, C. C. Progress in cancer chemoprevention. Ann. N. Y. Acad. Sci., 889: 1-13, 1999. (Pubitemid 30040420)
7. Hursting, S. D., Slaga, T. J., Fischer, S. M., DiGiovanni, J., and Phang, J. M. Mechanism-based cancer prevention approaches: targets, examples, and the use of transgenic mice. J. Natl. Cancer Inst. (Bethesda), 91: 215-225, 1999. (Pubitemid 29090990)
8. Wohlfart, R. Humulus. In: R. Hänsel, K. Keller, H. Rimpler, and G. Schneider (eds.), Hagers Handbuch der Pharmazeutischen Praxis, Vol. 5, Ed. 5, pp. 447-458. Berlin, Heidelberg: Springer, 1993.
9. Stevens, J. F., Miranda, C. L., Buhler, D. R., and Deinzer, M. L. Chemistry and biology of hop flavonoids. J. Am. Soc. Brew. Chem., 56: 136-145, 1998. (Pubitemid 29033045)
10. Hopfenzapfen, Lupuli flos. In: Europäisches Arzneibuch, Nachtrag 2000, Deutsche Ausgabe, Deutscher Apotheker-Verlag, Stuttgart: Govi- Verlag - Pharmazeutischer Verlag GmbH Eschborn, 2000.
11. Anonymus. Good news for beer drinkers. Science (Wash. DC), 274: 1309-1310, 1996.
12. Arimoto-Kobayashi, S., Sugiyama, C., Harada, N., Takeuchi, M., Takemura, M., and Hayatsu, H. J. Inhibitory effects of beer and other alcoholic beverages on mutagenesis and DNA adduct formation induced by several carcinogens. Agric. Food Chem., 47: 221-230, 1999. (Pubitemid 29179650)
13. Kimura, S., Hayatsu, H., and Arimoto-Kobayashi, S. Glycine betaine in beer as an antimutagenic substance against 2-chloro-4-methylthiobutanoic acid, the sanma-fish mutagen. Mutat. Res., 439: 267-276, 1999. (Pubitemid 29094819)
14. Henderson, M. C., Miranda, C. L., Stevens, J. F., Deinzer, M. L., and Buhler, D. R. In vitro inhibition of human P450 enzymes by prenylated flavonoids from hop, Humulus lupulus. Xenobiotica, 30: 235-251, 2000. (Pubitemid 30179138)
15. Miranda, C. L., Aponso, G. L., Stevens, J. F., Deinzer, M. L., and Buhler, D. R. Prenylated chalcones and flavanones as inducers of quinone reductase in mouse Hepa 1c1c7 cells. Cancer Lett., 149: 21-29, 2000. (Pubitemid 30100556)
16. Miranda, C. L., Stevens, J. F., Ivanov, V., McCall, M., Frei, B., Deinzer, M. L., and Buhler, D. R. Antioxidant and prooxidant actions of prenylated and nonprenylated chalcones and flavanones in vitro. J. Agric. Food Chem., 48: 3876-3884, 2000.
17. Miranda, C. L., Stevens, J. F., Helmrich, A., Henderson, M. C., Rodriguez, R. J., Yang, Y. H., Deinzer, M. L., Barnes, D. W., and Buhler, D. R. Antiproliferative and cytotoxic effects of prenylated flavonoids from hop (Humulus lupulus) in human cancer cell lines. Food Chem. Toxicol., 37: 271-285, 1999. (Pubitemid 29335754)
18. Milligan, S. R., Kalita, J. C., Heyerick, A., Rong, H., De Cooman, L., and De Keukeleire, D. Identification of a potent phytoestrogen in hop (Humulus lupulus L.) and beer. J. Clin. Endocrinol. Metab., 84: 2249-2252, 1999. (Pubitemid 30647064)
19. Tabata, N., Ito, M., Tomoda, H., and Omura, S. Xanthohumols, diacylglycerol acyltransferase inhibitors, from Humulus lupulus. Phytochemistry, 46: 683-687, 1997. (Pubitemid 27483829)
20. Hänsel, R., and Schulz J. Desmethylxanthohumol: Isolierung aus Hopfen und Cyclisierung zu Flavanonen. Arch. Phar. (Weinheim), 321: 37-40, 1988.
21. Gerhauser, C., Klimo, K., Heiss, E., Neumann, I., Gamal Eldeen, A., Knauft, J., Liu, G. Y., Sitthimonchai, S., and Frank, N. Mechanism-based in vitro screening of potential cancer chemopreventive agents. Mutat. Res., in press, 2002.
22. Crespi, C. L., Miller, V. P., and Penman, B. W. Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450. Anal. Biochem., 248: 188-190, 1997. (Pubitemid 27218241)
23. Stresser, D. M., Turner, S. D., Blanchard, A. P., Miller, V. P., and Crespi, C. L. Cytochrome P450 fluorometric substrates: identification of isoform-selective probes for rat CYP2D2 and human CYP3A4. Drug Metab. Dispos., 30: 845-852, 2002. (Pubitemid 34671098)
24. Cornish-Bowden, A. A simple graphical method for determining the inhibition constants of mixed, uncompetitive and non-competitive inhibitors. Biochem. J., 137: 143-144, 1974.
25. Cortes, A., Cascante, M., Cardenas, M. L., and Cornish-Bowden, A. Relationships between inhibition constants, inhibitor concentrations for 50% inhibition and types of inhibition: new ways of analyzing data. Biochem. J., 357: 263-268, 2001. (Pubitemid 32642925)
26. Gerhauser, C., You, M., Liu, J., Moriarty, R. M., Hawthorne, M., Mehta, R. G., Moon, R. C., and Pezzuto, J. M. Cancer chemopreventive potential of sulforamate, a novel analogue of sulforaphane that induces Phase 2 drug-metabolizing enzymes. Cancer Res., 57: 272-278, 1997. (Pubitemid 27036605)
27. Cao, G., and Prior, R. L. Measurement of oxygen radical absorbance capacity in biological samples. Methods Enzymol., 299: 50-62, 1999.
28. Ukeda, H., Maeda, S., Ishii, T., and Sawamura, M. Spectrophotometric assay for superoxide dismutase based on tetrazolium salt 3′, 1-(phe-nylamino)- carbonyl-3,4-tetrazolium]-bis(4-methoxy-6-nitro) benzenesulfonic acid hydrate reduction by xanthine-xanthine oxidase. Anal. Biochem., 251: 206-209, 1997. (Pubitemid 27392679)
29. Pick, E., and Mizel, D. Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader. J. Immunol. Methods, 46: 211-226, 1981. (Pubitemid 11020859)
30. Heiss, E., Herhaus, C., Klimo, K., Bartsch, H., and Gerhauser, C. Nuclear factor κB is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms. J. Biol. Chem., 276: 32008-32015, 2001.
31. Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., and Boyd, M. R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. (Bethesda), 82: 1107-1112, 1990. (Pubitemid 20213250)
32. Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W., Fong, H. H., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., Moon, R. C., and Pezzuto, J. M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science (Wash. DC), 275: 218-220, 1997. (Pubitemid 127696281)
33. Littlefield, B. A., Gurpide, E., Markiewicz, L., McKinley, B., and Hochberg, R. B. A simple and sensitive microtiter plate estrogen bioassay based on stimulation of alkaline phosphatase in Ishikawa cells: estrogenic action of delta 5 adrenal steroids. Endocrinology, 127: 2757-2762, 1990.
34. Markiewicz, L., Hochberg, R. B., and Gurpide, E. Intrinsic estrogenicity of some progestagenic drugs. J. Steroid Biochem. Mol. Biol., 41: 53-58, 1992.
35. Pengsuparp, T., Serit, M., Hughes, S. H., Soejarto, D. D., and Pezzuto, J. M. Specific inhibition of human immunodeficiency virus type 1 reverse transcriptase mediated by soulattrolide, a coumarin isolated from the latex of Calophyllum teysmannii. J. Nat. Prod., 59: 839-842, 1996. (Pubitemid 26337502)
36. Krishan, A. Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J. Cell Biol., 66: 188-193, 1975.
37. Gong, J., Traganos, F., and Darzynkiewicz, Z. A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal. Biochem., 218: 314-319, 1994. (Pubitemid 24141629)
38. Suh, N., Luyengi, L., Fong, H. H., Kinghorn, A. D., and Pezzuto, J. M. Discovery of natural product chemopreventive agents utilizing HL-60 cell differentiation as a model. Anticancer Res., 15: 233-239, 1995.
39. Mehta, R. G. Experimental basis for the prevention of breast cancer. Eur. J. Cancer, 36: 1275-1282, 2000. (Pubitemid 30407015)
40. Talalay, P., Fahey, J. W., Holtzclaw, W. D., Prestera, T., and Zhang, Y. Chemoprotection against cancer by phase 2 enzyme induction. Toxicol. Lett. (Amst.), 82-83: 173-179, 1995. (Pubitemid 26057505)
41. Kovacic, P., and Jacintho, J. D. Mechanisms of carcinogenesis: focus on oxidative stress and electron transfer. Curr. Med. Chem., 8: 773-796, 2001. (Pubitemid 32427906)
42. Ohshima, H., and Bartsch, H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat. Res., 305: 253-264, 1994. (Pubitemid 24082901)
43. Subbaramaiah, K., Zakim, D., Weksler, B. B., and Dannenberg, A. J. Inhibition of cyclooxygenase: a novel approach to cancer prevention. Proc. Soc. Exp. Biol. Med., 216: 201-210, 1997.
44. Reid, S. E., Murthy, M. S., Kaufman, M., and Scanlon, E. F. Endocrine and paracrine hormones in the promotion, progression and recurrence of breast cancer. Br. J. Surg., 83: 1037-1046, 1996. (Pubitemid 26291203)
45. Milligan, S. R., Kalita, J. C., Pocock, V., Van De Kauter, V., Stevens, J. F., Deinzer, M. L., Rong, H., and De Keukeleire, D. The endocrine activities of 8-prenylnaringenin and related hop (Humulus lupulus L.) flavonoids. J. Clin. Endocrinol. Metab., 85: 4912-4915, 2000. (Pubitemid 32157686)
46. Compagni, A., and Christofori, G. Recent advances in research on multistage tumorigenesis. Br. J. Cancer, 83: 1-5, 2000. (Pubitemid 30352708)
47. King, K. L., and Cidlowski, J. A. Cell cycle and apoptosis: common pathways to life and death. J. Cell. Biochem., 58: 175-180, 1995.
48. Steele, V. E., Sharma, S., Mehta, R., Elmore, E., Redpath, L., Rudd, C., Bagheri, D., Sigman, C. C., and Kelloff, G. J. Use of in vitro assays to predict the efficacy of chemopreventive agents in whole animals. J. Cell. Biochem. Suppl., 26: 29-53, 1996. (Pubitemid 27203751)
49. Wattenberg, L. J. Chalcones, myo-inositol and other novel inhibitors of pulmonary carcinogenesis. J. Cell. Biochem. Suppl., 22: 162-168, 1995.
50. Makita, H., Tanaka, T., Fujitsuka, H., Tatematsu, N., Satoh, K., Hara, A., and Mori, H. Chemoprevention of 4-nitroquinoline 1-oxide-induced rat oral carcinogenesis by the dietary flavonoids chalcone, 2-hydroxychalcone, and quercetin. Cancer Res., 56: 4904-4909, 1996. (Pubitemid 26374427)
51. Sinensky, M. Recent advances in the study of prenylated proteins. Biochim. Biophys. Acta, 1484: 93-106, 2000. (Pubitemid 30175960)
52. Miranda, C. L., Yang, Y. H., Henderson, M. C., Stevens, J. F., Santana-Rios, G., Deinzer, M. L., and Buhler, D. R. Prenylflavonoids from hops inhibit the metabolic activation of the carcinogenic heterocyclic amine 2-amino-3-methylimidazo[4, 5-f]quinoline, mediated by cDNA-expressed human CYP1A2. Drug Metab. Dispos., 28: 1297-1302, 2000.
53. Rodriguez, R. J., Miranda, C. L., Stevens, J. F., Deinzer, M. L., and Buhler, D. R. Influence of prenylated and non-prenylated flavonoids on liver microsomal lipid peroxidation and oxidative injury in rat hepatocytes. Food Chem. Toxicol., 39: 437-445, 2001. (Pubitemid 32323976)
54. Janssen-Heininger, Y. M., Poynter, M. E., and Baeuerle, P. A. Recent advances towards understanding redox mechanisms in the activation of nuclear factor κB. Free Radic. Biol. Med., 28: 1317-1327, 2000. (Pubitemid 30621476)
55. Cheng, Z., Lin, C., Hwang, T., and Teng, C. Broussochalcone A, a potent antioxidant and effective suppressor of inducible nitric oxide synthase in lipopolysaccharide-activated macrophages. Biochem. Pharmacol., 61: 939-946, 2001. (Pubitemid 32247382)
56. Howe, L. R., Subbaramaiah, K., Brown, A. M., and Dannenberg, A. J. Cyclooxygenase-2: a target for the prevention and treatment of breast cancer. Endocr. Relat. Cancer, 8: 97-114, 2001. (Pubitemid 32641352)
57. Watson, J., and Chuah, S. Y. Prostaglandins, steroids and human mammary cancer. Eur. J. Cancer Clin. Oncol., 21: 1051-1055, 1985. (Pubitemid 15227464)
58. Keshava, N., Mandava, U., Kirma, N., and Tekmal, R. R. Acceleration of mammary neoplasia in aromatase transgenic mice by 7,12-dimethylbenz[a] anthracene. Cancer Lett., 167: 125-133, 2001. (Pubitemid 32706674)
59. Suganuma, M., Ohkura, Y., Okabe, S., and Fujiki, H. Combination cancer chemoprevention with green tea extract and sulindac shown in intestinal tumor formation in Min mice. J. Cancer Res. Clin. Oncol., 127: 69-72, 2001.
60. Gerhauser, C., Mar, W., Lee, S. K., Suh, N., Luo, Y., Kosmeder, J., Luyengi, L., Fong, H. H., Kinghorn, A. D., Moriarty, R. M., Mehta, R. G., Constantinou, A., Moon, R. C., and Pezzuto, J. M. Rotenoids mediate potent cancer chemopreventive activity through transcriptional regulation of ornithine decarboxylase. Nat. Med., 1: 260-266, 1995.
61. Yilmazer, M., Stevens, J. F., and Buhler, D. R. In vitro glucuronidation of xanthohumol, a flavonoid in hop and beer, by rat and human liver microsomes. FEBS Lett., 491: 252-256, 2001. (Pubitemid 32193806)
62. Yilmazer, M., Stevens, J. F., Deinzer, M. L., and Buhler, D. R. In vitro biotransformation of xanthohumol, a flavonoid from hops (Humulus lupulus), by rat liver microsomes. Drug Metab. Dispos., 29: 223-231, 2001. (Pubitemid 32179520)
63. Stevens, J. F., Taylor, A. W., Clawson, J. E., and Deinzer, M. L. Fate of xanthohumol and related prenylflavonoids from hop to beer. J. Agric. Food Chem., 47: 2421-2428, 1999. (Pubitemid 29325134)
64. Gerhauser, C., Alt, A., Klimo, K., Heiss, E., Neumann, I., Gamal-Eldeen, A., Knauft, J., Scherf, R., Frank, N., Bartsch, H., and Becker, H. Xanthohumol from hop (Humulus lupulus) as a novel potential cancer chemopreventive agent. Proc. Am. Assoc. Cancer Res., 42: 18, 2001.